Gadolinium Toxicity MRI/MRA Lawsuits

Gadolinium is a chemical compound used in the administration of MRIs. It is a contrast dye, which helps generate higher quality images to assist medical professionals in diagnostic procedures. The chemical has been used for decades, helping radiologists view internal body structures, and is particular helpful when imaging tumors in major body organs such as the lungs or anywhere in the central nervous system.

Late last year, the FDA ordered a black box warning be placed on all contrast dyes used in MRA and MRI exams when it was discovered that those made of gadolinium could worsen the prognosis in individuals with chronic inflammatory conditions such as chronic kidney disease. The FDA went on to reiterate that this condition may develop even after one gadolinium agent injection, thereby cautioning healthcare providers to be wary of using it on the above named patients.

Gadolinium deposition disease occurs in the direct aftermath of an injection. It presents as pain in one’s arms or legs, bone pain, brain fog and the sensation of one’s tissue burning. This may be seen in individuals with adequate renal function, and may occur anywhere from a few hours to a number of weeks after receiving the gadolinium contrast agent injection. Gadolinium storage condition, on the other hand, refers to the excess exposure to gadolinium, with most of it building up and lingering in tissue in organs throughout the body, causing cardiac arrest, strokes, and seizures.

If you or a loved one has suffered complications from the use of contrast dye, you may be entitled to compensation. Contact the experienced lawyers at Neumann Law Group for a free consultation.